Topiramate slow release composition and preparation process thereof
A slow-release composition and topiramate technology, which is applied to medical preparations with non-active ingredients, medical preparations containing active ingredients, organic active ingredients, etc., can solve problems such as cumbersome production process, increased production cost, and narrow therapeutic window , to achieve the effect of reducing production cost, simplifying production process and facilitating quality control
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] A topiramate sustained-release composition, comprising the following components in parts by weight: 650 g of topiramate, 100 g of acrylic resin, 50 g of hypromellose, 100 g of talc, and 10 g of triethyl citrate.
[0022] The preparation technology of described topiramate composition is:
[0023] (1) take by weighing 100g acrylic ester resin by formula quantity and be made into the solution that mass fraction is 10%, used solvent is 70% ethanol;
[0024] (2) Add 50g hypromellose, 100g talcum powder, and 10g triethyl citrate to the above-mentioned ethanol solution to form a coating solution;
[0025] (3) take by weighing 650g topiramate and put in the powder coating machine, carry out powder coating with above-mentioned coating solution;
[0026] (4) Drying at 30° C. for 8 hours after coating is completed to obtain the topiramate sustained-release composition.
Embodiment 2
[0028] A topiramate sustained-release composition, comprising the following components in parts by weight: 300 g of ethyl cellulose, 200 g of hydroxypolyethylene glycol, 200 g of magnesium stearate, 30 g of dibutyl sebacate, and 850 g of topiramate.
[0029] The preparation technology of described topiramate composition is:
[0030] (1) taking by weighing 300g ethylcellulose is made into the solution that mass fraction is 30%, and used solvent is the ethanol of 90%;
[0031] (2) Add 200g polyethylene glycol, 200g magnesium stearate, and 30g dibutyl sebacate to the above ethanol solution to form a coating solution;
[0032] (3) take by weighing 850g topiramate and put in the powder coating machine, carry out powder coating with above-mentioned coating solution;
[0033] (4) Drying at 50° C. for 14 hours after coating is completed to obtain the topiramate sustained-release composition.
Embodiment 3
[0035] A topiramate sustained-release composition, comprising the following components in parts by weight: 200 g of ethyl cellulose, 130 g of oxypovidone, 150 g of silicon dioxide, 20 g of triethyl citrate, and 750 g of topiramate.
[0036] The preparation technology of described topiramate composition is:
[0037] (1) taking by weighing 200g propylene ester resin is made into the solution that mass fraction is 20%, and used solvent is the ethanol of 80%;
[0038] (2) Add 130g povidone, 150g silicon dioxide and 20g triethyl citrate to the above ethanol solution to form a coating solution;
[0039] (3) Take by weighing 750g bulk drug and put in the powder coating machine, carry out powder coating with above-mentioned coating solution;
[0040] (4) Drying at 40° C. for 11 hours after coating is completed, to obtain the topiramate sustained-release composition.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 